Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Melanoma (Skin Cancer): early-phase trial registry

6 of 6 indexed Melanoma (Skin Cancer) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 6 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Melanoma (Skin Cancer): 6 US clinical trials tracked, 6 recruiting.

Melanoma (Skin Cancer) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Aminex Therapeutics, running 1 of these trials.

Enrollment posture brief

Registry condition melanoma-skin-cancer

OPEN 6 | RECR 100% | LATE 0 | EARLY 4 | RANK #2866 | SPON 1

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Melanoma (this)100%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Melanoma (Skin Cancer)

Melanoma (Skin Cancer) lists 6 open slots (100% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Melanoma (Skin Cancer) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Melanoma (Skin Cancer) is recruiting above its size-band peers.

    6 of 6 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Melanoma (Skin Cancer) research.

    Aminex Therapeutics accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical Melanoma (Skin Cancer) enrolment sits around 100 participants.

    Median target enrolment is 100 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Melanoma (Skin Cancer) splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Top Sponsors

Aminex Therapeutics 1 trials
Paradigm Health 1 trials
Linnaeus Therapeutics 1 trials
Iovance Biotherapeutics 1 trials
M.D. Anderson Cancer Center 1 trials
University of Wisconsin, Madison 1 trials

Named interventions

Most-linked intervention names on Melanoma (Skin Cancer) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

AMXT 1501 Dicaprate Drug
1 trials
Alpelisib + Pembrolizumab Drug
1 trials
blood and tissue samples Other
1 trials
blood and tissue samples Diagnostic test
1 trials
Immunotherapy (nivolumab and relatlimab) Biological
1 trials
Immunotherapy (Pembrolizumab) Biological
1 trials
Chemotherapy (dacarbazine or temozolomide) Drug
1 trials
LNS8801 Biological
1 trials

US sites by state

Facility locations filed on Melanoma (Skin Cancer) trials. A trial with sites in several states counts in each.

California 3 trials
Wisconsin 2 trials
Texas 2 trials
Virginia 1 trials
Utah 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Melanoma (Skin Cancer) page

6 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 6 Melanoma (Skin Cancer) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Aminex Therapeutics sponsors the most Melanoma (Skin Cancer) trials on record, review their full trial history before evaluating a specific study. See Aminex Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Melanoma (Skin Cancer) condition card totals 6 registered trials; most-linked intervention AMXT 1501 Dicaprate; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.